mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
-0.042 |
0.8 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
KIN001-260 |
GDSC1000 |
pan-cancer |
AAC |
-0.0084 |
0.8 |
mRNA |
Bortezomib |
FIMM |
pan-cancer |
AAC |
-0.043 |
0.8 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.8 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.8 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |